Testing effectiveness (Phase 2)Active Not RecruitingNCT06335173
What this trial is testing
Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 542